Experimental Cell Research 2013-12-10

Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation

Rajendra Karki, Seong-Bin Kim, Dong-Wook Kim

Index: Exp. Cell Res. 319(20) , 3238-50, (2013)

Full Text: HTML

Abstract

Background Increased proliferation and migration of vascular smooth muscle cells (VSMCs) contribute importantly to the formation of both atherosclerotic and restenotic lesions. The objective of this study was to investigate the effect of magnolol on VSMC migration.

Related Compounds

  • Magnolol

Related Articles:

Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.

2015-07-01

[J. Pharm. Sci. 104 , 2369-77, (2015)]

Resuscitation from experimental traumatic brain injury by magnolol therapy.

2013-10-01

[J. Surg. Res. 184(2) , 1045-52, (2013)]

Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.

2015-10-01

[Cancer Sci. 106 , 1341-50, (2015)]

Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway.

2013-09-01

[Pharmazie 68(9) , 755-62, (2013)]

Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.

2010-09-01

[Molecules 15(9) , 6452-65, (2010)]

More Articles...